Nektar Therapeutics, Inc. - Common Stock, par value $0.0001 per share (NKTR)

CUSIP: 640268108

Q4 2013 13F Holders as of 31 Dec 2013

Type / Class
Equity / Common Stock, par value $0.0001 per share
Shares outstanding
20,788,527
Total 13F shares
102,538,821
Share change
-198,668
Total reported value
$1,164,043,258
Put/Call ratio
98%
Price per share
$11.35
Number of holders
134
Value change
-$2,254,562
Number of buys
2
Number of sells
2

Quarterly Holders Quick Answers

What is CUSIP 640268108?
CUSIP 640268108 identifies NKTR - Nektar Therapeutics, Inc. - Common Stock, par value $0.0001 per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of Nektar Therapeutics, Inc. - Common Stock, par value $0.0001 per share (NKTR) as of Q4 2013

As of 31 Dec 2013, Nektar Therapeutics, Inc. - Common Stock, par value $0.0001 per share (NKTR) was held by 134 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 102,538,821 shares. The largest 10 holders included OPPENHEIMER FUNDS INC, PRIMECAP MANAGEMENT CO/CA/, VANGUARD GROUP INC, FEDERATED INVESTORS INC /PA/, BlackRock Fund Advisors, FIRST TRUST ADVISORS LP, State Street Corp, Bank of New York Mellon Corp, GRANAHAN INVESTMENT MANAGEMENT INC/MA, and BlackRock Institutional Trust Company, N.A.. This page lists 134 institutional shareholders reporting positions in this security for the Q4 2013 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.